Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model

[Image: see text] Estrogen receptor β (ERβ) selective agonists are considered potential therapeutic agents for a variety of pathological conditions, including several types of cancer. Their development is particularly challenging, since differences in the ligand binding cavities of the two ER subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterni, Ilaria, Bertini, Simone, Granchi, Carlotta, Tuccinardi, Tiziano, Macchia, Marco, Martinelli, Adriano, Caligiuri, Isabella, Toffoli, Giuseppe, Rizzolio, Flavio, Carlson, Kathryn E., Katzenellenbogen, Benita S., Katzenellenbogen, John A., Minutolo, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610302/
https://www.ncbi.nlm.nih.gov/pubmed/25559213
http://dx.doi.org/10.1021/jm501829f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610302/
https://www.ncbi.nlm.nih.gov/pubmed/25559213
http://dx.doi.org/10.1021/jm501829f

Ejemplares similares